Climb Bio, Inc. Gains 30.43%
Fri, Dec 12, 2025 at 07:35 PM
Climb Bio, Inc. (CLYM:NASDAQ) jumped higher at $3, a gain of 30.4%. On Fri, Dec 12, 2025, CLYM:NASDAQ hit a New 2-Week High of $3. The stock got featured on our News Catalysts scanner on Tue, Nov 25, 2025 at 09:08 AM in the 'PRIVATE PLACEMENT' category. From Mon, Dec 01, 2025, the stock recorded 66.67% Up Days and 60.00% Green Days
About Climb Bio, Inc. (CLYM:NASDAQ)
Eliem Therapeutics Inc is a clinical-stage biotechnology company.
Top 10 Gainers:
- cbdMD, Inc. (YCBD:NYSEMKT), 90.17%
- TryHard Holdings Limited (THH:NASDAQ), 57.72%
- Neo-Concept International Group Holdings Limited (NCI:NASDAQ), 54.84%
- Canopy Growth Corporation (CGC:NASDAQ), 53.98%
- RYTHM Inc Com Par $0.001 (New) (RYM:NASDAQ), 47.73%
- Tilray Brands, Inc. (TLRY:NASDAQ), 44.13%
- Hydrofarm Holdings Group, Inc. (HYFM:NASDAQ), 36.3%
- AlphaVest Acquisition Corp (ATMV:NASDAQ), 31.3%
- Basel Medical Group Ltd (BMGL:NASDAQ), 30.92%
- Climb Bio, Inc. (CLYM:NASDAQ), 30.43%